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Introduction  
Most persistent organic pollutants (POPs) like polychlorinated biphenyls (PCBs), a range of polybrominated 
diphenyl ethers (PBDEs) and organochlorine pesticides (OCPs) are readily absorbed (via the ingestion and 
inhalation) and accumulate in fatty tissue, including adipose tissue and human milk [1]. Health effects related to 
exposure to these chemicals may include neurological effects, altered functioning of the nervous system and/or 
endocrine disruption [2-4]. The burden of environmental disease is recognized as much higher for children than 
adults, especially in young children under 5 years of age worldwide [5]. There is increased concern regarding the 
environmental impact on the health of children who have been disproportionately affected by environmental 
problems. For example they may be subjected to relatively higher exposure, have greater physiological 
susceptibility and/or suffer more extreme consequences due to growth [6-9]. It is therefore worthwhile to assess 
the correlation between burden of disease and exposure to xenobiotic chemical pollutants like POPs. Such 
assessment may provide guidance for legislative changes regarding chemical bans and give reliable advice to 
parents including lactating mothers. 
 
The conventional technique of measuring body burden for POPs is via collection and analysis of serum. 
However with children, collection of sufficient serum for analysis of trace organic pollutants remains typically 
‘too difficult’ with respect to ethics, consent/participation and feasibility (i.e. requirement for multiple sampling 
to get sufficient volume) [10]. This problem with sample volume has been overcome in some studies by pooling 
samples from groups of individuals, however, this approach is not suitable for longitudinal assessments of body 
burden during infancy and early childhood when exposure is least understood.  
 
For a range of persistent lipophilic organic pollutants, it has been shown that desorption from the body into the 
lumen of the digestive tract followed by fecal excretion is one of the major mechanisms for physical elimination 
[11-12]. Early evidence came from studies on breast fed children which showed that faecal excretion of 
polychlorinated dibenzodioxins and furans (PCDD/PCDFs) did not change/decrease over the weaning period 
despite the fact that exposure/uptake via breast milk was estimated to be much higher than in the substituted diet 
[13]. Moser and McLachlan further suggested that the fecal levels of a range of POPs are determined by their 
concentration in the body, not in the diet [16]. A feces/blood distribution coefficient KFB was defined as the 
quotient of the dry weight-based concentration in feces and the lipid-based concentration in blood demonstrating 
that the dry weight-based faeces concentration can be linearly related to the lipid-based blood concentration over 
a very wide range. Therefore, with the use of KFB, fecal POPs have the potential to make a reliable biomarker for 
the body burden of POPs. McLachlan and team undertook a range of systematic studies expanding the concept 
with the aim to increase clearance of POPs using non-digestible fat, however the focus of their work was 
primarily on parameterizing a model for the uptake and clearance of POPs in humans and not on applying the 
approach to estimating body burden. 
 
With the present study we aim to quantify POPs in faeces of infants/toddlers. Furthermore, in this preliminary 
study we aim to compare the measured concentrations of POPs in the faeces to recent Australian data from 
pooled children (0-4 years in age) blood serum [15].  
 
Materials and methods  
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Sample Collection and Storage 
For this study, we recruited 5 infants and 2 toddlers from families of at least two years’ residence in Brisbane, 
Australia, who originate from several countries (Table 1).  
 
Table 1 Demographics of infants/toddlers including national background of parents, year of birth, age of 
mother and child at sample collection and feeding status 
Subject Gender 
Parents’ 
nationality/Residence 
years in Australia 
The 
year 
of 
birth 
Mother’s 
age at the 
year of 
birth 
Primipara 
or other 
Age at the time 
of sampling 
Feeding component 
at the time of 
sampling 
Infant 1 Male Canada/2 years 2012 34 Primipara 
6 month-11 
months 
Breast milk/formula 
milk/solid food 
Infant 2 Male New Zealand/3 years 2012 33 Primipara 5-6 months Breast milk/solid food 
Infant3* Female 
Malaysia & Chinese/4 
years 
2012 36 Second 5-6 months 
Breast milk/formula 
milk 
Infant 4 Female Australia 2012 32 Primipara 7 months 
Breast milk/formula 
milk/solid food 
Infant 5 Female Australia 2012 40 Primipara 7months 
Breast milk/formula 
milk/solid food 
Toddler 1 Female Australia 2010 33 Primipara 2 years Solid food 
Toddler2* Male 
Malaysia & Chinese/4 
years 
2010 34 Primipara 2 years  and half 
Formula milk/solid 
food 
*Toddler 2 and Infant 3 are from a vegetarian family. 
 
Parents collected faecal samples twice a week for one month for each individual child. Sample collections were 
done by directly taking a portion of the faeces that was not in contact with the nappy (or from a liner applied on 
top of the nappy which can help retain a dry portion of the faeces). Nappy and liner materials were also analyzed 
as QCQA samples with very low concentration of POPS observed. Samples were freeze-dried and stored at -
80 
°
C in clean amber jars covered by PTFE-lined screw lid until extraction. 
 
 Sample extraction and clean-up 
3 gram aliquots of the dried faeces samples as well as a blank consisting of bovine calf serum were placed in a 
diodonium cell with 3 grams of hydromatirx. The samples were then spiked with internal standards and extracted 
using n-hexane in an Accelerated Solvent Extractor (ASE), at 100 
°
C, 1500 psi using 3 static cycles of 7 minutes. 
The extracts were cleaned up on a multilayered column (30 cm ×1 cm i.d.), having Na2SO4, KOH silica, neutral 
silica, 44% acid silica, 22% acid silica, neutral silica and Na2SO4 from bottom to top. PCBs, OCPs and PBDEs 
were eluted with 80 ml of Hexane. The hexane extractable ‘lipid content’ of the samples was determined in a 
separate extraction in the ASE using the above conditions where the hexane was evaporated to dryness and the 
‘lipid content’ was determined gravimetrically. 
  
Sample analysis 
All samples were analyzed for indicator PCBs, OCPs and PBDEs using a GCMS-QP2010 Plus operated in 
negative chemical ionization (NCI) mode. An Rxi® -XLB columns (fused silica) 0.28mm (i.d.)×25m fused silica 
capillary column was used.  The injection port and transfer line temperatures were maintained at 270 
°
C and 
280 
°
C, respectively, and the oven temperature program was 80 
°
C for 3 min, then 20 
°
C min
-1
 to 320 
°
C and 
finally 320 
°
C for 6 min; total run-time 25 min. The mass spectrometer operating conditions were as follows: ion 
source 280 
°
C; ionization energy 38 eV; electron multiplier voltage set to 300 V. Selective Ion Monitoring (SIM) 
experiments were performed for each homolog. 
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Table 2 Concentration of indicator PCBs, PBDEs and OCPs in faeces from one infant (duplicate) and one toddler. And the ratios of them to the 
concentration in a pooled blood sample analyzed at 2008/9. 
Compound 
 
Concentration in 
Infant faeces * 
(ng/g lipid) 
CFi1 +SD  (CV) 
Concentration in 
Toddler faeces 
(ng/g lipid) 
CFi2 
Concentration in 
Pooled Infants 
Blood
# 
(ng/g lipid) CBP 
Infant faeces* to Pooled 
Blood
#   
ratio CFi1/CBP 
Toddler faeces to Pooled 
Blood
#
 ratio  CFi2
/
CBp 
PCB 
28 0.30 ± 0.06 (20) 0.59 1.2 0.25 0.49 
52 0.17 ± 0.01 (5.9) 0.35 n.d.(0.5) - - 
101 0.25 ± 0.02 (8.0) 0.30 n.d.(0.5) - - 
118 0.78 ± 0.06 (7.7) 1.8 1.4 0.55 1.3 
153 1.7 ± 0.10 (5.9) 1.7 3.4 0.51 0.49 
138 1.3 ± 0.23 (18) 2.2 2 0.65 1.1 
180 0.83 ± 0.01 (1.2) 0.60 2.3 0.36 0.26 
PBDE 
28 0.94 ± 0.93 (99) 0.19 0.5 1.9 0.38 
47 4.4 ± 0.31 (7.0) 5.0 13 0.33 0.38 
49 0.15 ± 0.01 (6.7) 0.15 n.d.(0.5) - - 
66 0.04 ± 0.01 (25) 0.04 n.d.(0.5) - - 
85 0.44 ± 0.40 (91) 0.62 0.50 0.88 1.2 
99 2.3 ± 1.3 (57) 3.9 4.8 0.90 0.81 
100 1.9 ± 0.35 (18) 3.4 3.4 0.54 1.00 
153 0.45 ± 0.23 (51) 1.0 3.2 0.14 0.31 
154 0.11 ± 0.08 (73) 0.32 0.50 0.21 0.64 
183 0.32 ± 0.39 (122) 0.04 0.50 0.63 0.08 
DDT 0.70 ± 0.11 (16) 0.89 12 0.06 0.07 
DDE 2.2 ± 0.24 (11) 3.1 280 0.01 0.01 
HCB 0.52 ± 0.10 (19) 0.58 5.4 0.10 0.11 
(ϒ-HCH) Lindan 0.40 ± 0.17 (43) 0.20 n.d. (2.4) - - 
Heptachlor 0.70 ± 0.02 (2.9) 0.79 n.a. - - 
t-chlordane 0.19 ± 0.08 (42) 0.37 n.a. - - 
c-chlordane 0.24 ± 0.17 (71) 0.19 n.a. - - 
 *: Based on 2 replicate of a split sample 
#:  Concentration of p (ng/g lipid) for age group of 0-4 years in Australia for 2008/09 (Source:  Chemical Monitoring Initiative: Australian human blood 
sample collection and chemical testing—Final Report 
n.d. : not detected followed by the value in brackets which is the limit of detection;                                    n.a.: not analysed 
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Results and Discussion 
7 PCBs, 10 PBDEs as well as a series of OCPs could be detected in the two faeces samples analyzed to date 
(Table 2). The mean CV for analyzing replicates of a pool of multiple samples collected from the infant was 
34 % for the 24 compounds detected, where 15 of the 24 compounds had a CV < 28 % (ie. replicates deviate by 
less than a factor 1.5).  Consistently good reproducibility was found for the PCBs whereas reproducibility was 
lowest for a range of the BDEs as well as chlordanes and HCH. 
 
Overall the concentrations of POPs in the faeces from these one infant and one toddler were relatively similar 
and dominated by few PCBs (ie PCB 153, 138 and 118), BDE 47, 99, 100 and DDE which were found in the 
range of 1 to 5 pg/g lipid. These profiles in faeces are similar to that observed in pooled blood of children from 
Australia. In detail, on a lipid weight basis, concentration in the faeces of the main PCBs and BDEs in the infant 
range from about one third (BDE 47) to nearly equal (BDE 99) when compared to pooled blood collected in 
2009 from 0 – 4 year old children. In contrast concentrations of OCPs were found at much lower levels than in 
the pooled blood (i.e. 1 – 10% for DDTs and HCB respectively).    
 
The data also suggest that the levels of selected POPs were slightly higher in the faeces of the toddler compared 
with those from the infant which was somewhat unexpected. More work is required to assess whether this is a 
significant difference and if so, what factors this relates to (ie length of breast feeding, difference in intake) 
 
On the whole our study showed that POPs can be identified using faecal samples collected from small children.  
The future goal is to assess whether we can use the concentration of POPs in faeces for estimating the 
concentration in blood lipid and therefore the body burden of POPs in the children.  More work is underway to 
calibrate the underlying model where ideally we plan to obtain matched faeces and blood samples from same 
children.. 
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